Speech treatment improves dysarthria in multisystemic ataxia: a rater-blinded, controlled pilot-study in ARSACS

J Neurol. 2019 May;266(5):1260-1266. doi: 10.1007/s00415-019-09258-4. Epub 2019 Mar 6.

Abstract

We aimed to provide proof-of-principle evidence that intensive home-based speech treatment can improve dysarthria in complex multisystemic degenerative ataxias, exemplified by autosomal recessive spastic ataxia Charlevoix-Saguenay (ARSACS). Feasibility and piloting efficacy of speech training specifically tailored to cerebellar dysarthria was examined through a 4-week program in seven patients with rater-blinded assessment of intelligibility (primary outcome) and naturalness and acoustic measures of speech (secondary outcomes) performed 4 weeks before, immediately prior to, and directly after training (intraindividual control design). Speech intelligibility and naturalness improved post treatment. This provides piloting evidence that ataxia-tailored speech treatment might be effective in degenerative cerebellar disease.

Keywords: Acoustics; Ataxic neuropathy; Dysarthria; Rehabilitation; Speech; Voice.

Publication types

  • Multicenter Study

MeSH terms

  • Dysarthria / etiology*
  • Dysarthria / rehabilitation*
  • Feedback, Sensory / physiology
  • Female
  • Humans
  • Male
  • Muscle Spasticity / complications*
  • Outcome Assessment, Health Care
  • Pilot Projects
  • Speech Therapy / methods*
  • Spinocerebellar Ataxias / complications
  • Spinocerebellar Ataxias / congenital*
  • Statistics, Nonparametric

Supplementary concepts

  • Spastic ataxia Charlevoix-Saguenay type